Archive Uncategorized

Now available: “Pharmaceutical Management Considerations for UHC” Webinar Recording

On Monday, March 19, SIAPS presented its webinar “Pharmaceutical Management Considerations for UHC.” This webinar discussed the practical steps needed to tailor pharmaceutical management efforts to meet UHC objectives, including expanded coverage of essential health services and financial risk protection. Please find the presentation here and the recording as well as additional resources below: Resources … Read more

SIAPS Voices Blog Series

  Working for improved access to HIV treatment in Namibia Greatjoy Mazibuko, SIAPS Senior Technical Manager in Namibia Rebuilding Sierra Leone’s pharmaceutical system post-Ebola Murtada Sesay, SIAPS Country Project Director in Sierra Leone Can we vanquish malaria for good? Andwele Mwansasu, MD, SIAPS Senior Technical Advisor A new push to improve access to lifesaving medicines … Read more

Focus on Scale

Key to the success of any health systems strengthening project is whether it effects broad, sustainable, institutional change.  Sound strategic planning can grow a successful hospital pilot program into a nationwide health intervention that improves lives.  The examples below show the SIAPS program’s work in bringing pharmaceutical systems strengthening interventions to scale.     Technical Publication: Transforming Pharmaceutical … Read more

Bangladesh Health and Family Welfare Minister Officially Launches SDP Dashboard Module

The Service Delivery Point (SDP) Dashboard Module of the Directorate General of Family Planning’s (DGFP) electronic Logistics Management Information System (eLMIS; https://scmpbd.org/index.php/lmis-dashboard) was formally launched on November 30, 2016, at the Hotel Pan Pacific Sonargaon, Dhaka (the system was rolled out and has been used since June 2015). The Honorable Minister Mohammad Nasim, Member of … Read more

SIAPS Case by Case

Individually each one of the case examples below describes interventions, strategies, and actions taken to deliver results in specific areas of governance, capacity building, data for decision-making, supply chain, and pharmaceutical services.  Collectively, they show the breadth of the SIAPS Program’s achievements in pharmaceutical systems strengthening. Note: These case examples were published in May 2015 in … Read more

Focus on: Human Resources Capacity

Comprehensive strategies and actions for monitoring the safety of medicines are essential to a well-functioning pharmaceutical sector. The links below highlight recent SIAPS Program work in building human resources capacity in health for resilient pharmaceutical systems. Highlighted Tool: CRMS Developed in 2009, initially to bolster malaria treatment, CRMS has proven valuable in tracking performance trends … Read more

New course on good governance in the management of medicines now available

From the development of sound policies and legislation, to the selection, procurement, and distribution of medicines; governance issues permeate all levels of the pharmaceutical sector and heavily influence the availability and accessibility of medicines and other health commodities. The USAID-funded SIAPS project is pleased to announce the launch of a new course on USAID’s Global Health … Read more

Estrategias basadas en evidencia para la racionalización de la lista de medicamentos de alto costo en la Republica Dominicana

El Ministerio de Salud Pública (MSP) de República Dominicana organizó el Programa de Medicamentos de Alto Costo (PMAC) en 2008[i] con el propósito de facilitar atenciones clínicas a pacientes con patologías de muy baja prevalencia y alto costo de tratamiento, como cánceres refractarios a tratamientos convencionales, artritis reumatoide, hepatitis C y trasplante renal, entre otras. … Read more

, , ,

Evidence-based strategies for the rationalization of the list of high-cost medicines in the Dominican Republic

The Ministry of Public Health (Ministerio de Salud Pública, or MSP) of the Dominican Republic organized the High-Cost Medicines Program (Programa de Medicamentos de Alto Costo, or PMAC) in 2008[i] to facilitate clinical care for patients with very rare diseases and high-cost treatment, such as cancers unresponsive to conventional treatments, rheumatoid arthritis, hepatitis C, and … Read more

, , ,

New Global Health eLearning Course published on antimicrobial resistance

The second in the series, the newly published, SIAPS-authored course on Antimicrobial Resistance expands upon the concepts presented in Part 1 and explains the major factors that contribute to the development and spread of antimicrobial resistance. The course also explores some of the proven interventions and global strategies currently being used to combat AMR, reviews … Read more